Arschang Valipour, Vienna, Austria, met with us at ERS 2019 in Madrid to discuss the 6-month results from a prospective multi-center study of bronchial rheoplasty for the treatment of chronic bronchitis.
Questions
1. What are the most important unmet needs in the treatment of patients with chronic bronchitis? (0:05)
2. Could you tell us a little about the design of the RheOx™ device and its mechanism of action? (0:45)
3. What was the design of the recent prospective study investigating this technique? (1:39)
4. What were the major efficacy and safety findings of this study? (2:54)
5. What will be the next steps in the clinical investigation of the RheOx™ device? (3:54)
Speaker disclosures: Arschang Valipour has nothing to disclose in relation to this interview.
touchRESPIRATORY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at the European Respiratory Society (ERS) International Congress 2019, Madrid, Spain.
